Adrenarche, pubertal development, age at menarche and final height of full-term, born small for gestational age (SGA) girls

被引:67
作者
Ghirri, P [1 ]
Bernardini, M [1 ]
Vuerich, M [1 ]
Cuttano, AMR [1 ]
Coccoli, L [1 ]
Merusi, I [1 ]
Ciulli, C [1 ]
D'Accavio, L [1 ]
Bottone, U [1 ]
Boldrini, A [1 ]
机构
[1] Univ Pisa, Osped Chiara, Div Neonatol, I-56100 Pisa, Italy
关键词
SGA; growth; puberty; menarche; adrenarche; final height;
D O I
10.1080/713602799
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Children born small for gestational age (SGA) may present advanced bone maturation in childhood and reduced final height. The objectives of the study were to evaluate adrenarche, pubertal development, age at menarche and final height in full-term born-SGA girls. Twenty-four girls (12 born-SGA and 12 matched controls) were evaluated at 6-7.5 years of age for clinical signs of puberty and dehydroepiandrosterone sulfate (DNEAS) levels, as a marker of adrenarche. Thirty-eight girls (19 born-SGA and 19 matched controls) were evaluated at 17.5-18.5 years of age to assess final height, sexual maturation and age at menarche. SGA girls had a mean final height (160.1 cm vs 165.8 cm, p < 0.01) and mean weight (52.1 kg vs 56.5 kg, p < 0. 05) significantly lower than controls. Controls had a mean final height significantly higher than their mean target height. Sexual maturation was at stage 5 of Tanner's staging in SGA girls and control subjects. SGA girls had a slightly anticipated puberty (9.9 vs 10.4 years for initial breast development) and a lower age at menarche (11.9 vs 22.3 years). At 6-7.5 years of age, SGA females and controls did not show any difference for clinical signs of puberty; however, DHEAS levels (0.75 + 0. 18 mug/ml vs 0.57 + 0.22 mug/ml, p < 0. 05) were significantly higher in SGA girls than in control subjects. We concluded that full-term born-SGA females have impaired final height and weighs in adolescence but substantially normal sexual maturation and age at menarche. Increased DHEAS levels before puberty in born-SGA girls may predispose to increased bone maturation in childhood with a reduced final height. In our population a progressive increment in final stature is evident.
引用
收藏
页码:91 / 97
页数:7
相关论文
共 52 条
[11]  
Boguszewski M, 1997, ACTA PAEDIATR, V86, P189
[12]   Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age [J].
Boguszewski, M ;
Jansson, C ;
Rosberg, S ;
AlbertssonWikland, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (11) :3902-3908
[13]   DOSE-DEPENDENT CATCH-UP GROWTH AFTER 2 YEARS OF GROWTH-HORMONE TREATMENT IN INTRAUTERINE GROWTH-RETARDED CHILDREN [J].
CHATELAIN, P ;
JOB, JC ;
BLANCHARD, J ;
DUCRET, JP ;
OLIVIER, M ;
SAGNARD, L ;
VANDERSCHUERENLODEWEYCKX, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (06) :1454-1460
[14]   Growth hormone secretion and sensitivity in children born small for gestational age [J].
Chatelain, PG ;
Cauderay, MC ;
deZegher, F ;
Claris, O ;
Salle, B ;
Tauber, M ;
Chaussain, JL .
ACTA PAEDIATRICA, 1996, 85 :15-16
[15]   Short stature associated with intrauterine growth retardation: Final height of untreated and growth hormone-treated children [J].
Coutant, R ;
Carel, JC ;
Letrait, M ;
Bouvattier, C ;
Chatelain, P ;
Coste, J ;
Chaussain, JL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (04) :1070-1074
[16]  
Czernichow P, 1997, ACTA PAEDIATR, V86, P213
[17]   Intrauterine growth pattern and risk of childhood onset insulin dependent (type I) diabetes: Population based case-control study [J].
Dahlquist, G ;
Bennich, SS ;
Kallen, B .
BRITISH MEDICAL JOURNAL, 1996, 313 (7066) :1174-1177
[18]  
De Agostinis L, 1997, SININFORMA, VIII, P1
[19]   Growth hormone treatment of short children born small for gestational age: Metanalysis of four independent, randomized, controlled, multicentre studies [J].
deZegher, F ;
AlbertssonWikland, K ;
Wilton, P ;
Chatelain, P ;
Jonsson, B ;
Lofstrom, A ;
Butenandt, O ;
Chaussain, JL .
ACTA PAEDIATRICA, 1996, 85 :27-31
[20]   High-dose growth hormone treatment of short children born small for gestational age [J].
deZegher, F ;
Maes, M ;
Gargosky, SE ;
Heinrichs, C ;
DuCaju, MVL ;
Thiry, G ;
DeSchepper, J ;
Craen, M ;
Breysem, L ;
Lofstrom, A ;
Jonsson, P ;
Bourguignon, JP ;
Malvaux, P ;
Rosenfeld, RG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (05) :1887-1892